Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Profit from core business operations before interest and taxes
Latest
$-21.78M
↑ 37% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineStrong
Average
$-34.47M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-21.78M | -1.4% |
| 2024 | $-21.48M | +13.2% |
| 2023 | $-24.73M | -9.8% |
| 2022 | $-22.52M | +54.2% |
| 2021 | $-49.21M | -86.1% |
| 2020 | $-26.45M | +32.0% |
| 2019 | $-38.88M | +7.0% |
| 2018 | $-41.80M | -7.4% |
| 2017 | $-38.90M | +34.0% |
| 2016 | $-58.97M | - |